111 related articles for article (PubMed ID: 8971086)
21. Glucose transport activity in insulin-resistant rat muscle. Effects of angiotensin-converting enzyme inhibitors and bradykinin antagonism.
Henriksen EJ; Jacob S; Augustin HJ; Dietze GJ
Diabetes; 1996 Jan; 45 Suppl 1():S125-8. PubMed ID: 8529793
[TBL] [Abstract][Full Text] [Related]
22. Effect of valsartan and captopril in rabbit carotid injury. Possible involvement of bradykinin in the antiproliferative action of the renin-angiotensin blockade.
Feng TC; Ying WY; Hua RJ; Ji YY; de Gasparo M
J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):19-24. PubMed ID: 11881060
[TBL] [Abstract][Full Text] [Related]
23. Chronic vasopeptidase inhibition restores endothelin-converting enzyme activity and normalizes endothelin levels in salt-induced hypertension.
Quaschning T; d'Uscio LV; Shaw S; Viswambharan H; Ruschitzka FT; Lüscher TF
Nephrol Dial Transplant; 2001 Jun; 16(6):1176-82. PubMed ID: 11390717
[TBL] [Abstract][Full Text] [Related]
24. Alterations in angiotensin II release and vascular reactivity in hypertensive men: a pilot study.
Gasic S; Ratheiser K; Wagner O; Nowotny P; Vierhapper H; Waldhäusl W
Am J Hypertens; 1999 Nov; 12(11 Pt 1):1055-62. PubMed ID: 10604480
[TBL] [Abstract][Full Text] [Related]
25. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo.
Ferri C; Pittoni V; Piccoli A; Laurenti O; Cassone MR; Bellini C; Properzi G; Valesini G; De Mattia G; Santucci A
J Clin Endocrinol Metab; 1995 Mar; 80(3):829-35. PubMed ID: 7883838
[TBL] [Abstract][Full Text] [Related]
26. Eicosapentaenoic acid suppresses basal and insulin-stimulated endothelin-1 production in human endothelial cells.
Chisaki K; Okuda Y; Suzuki S; Miyauchi T; Soma M; Ohkoshi N; Sone H; Yamada N; Nakajima T
Hypertens Res; 2003 Aug; 26(8):655-61. PubMed ID: 14567505
[TBL] [Abstract][Full Text] [Related]
27. Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies.
Hock FJ; Wirth K; Albus U; Linz W; Gerhards HJ; Wiemer G; Henke S; Breipohl G; König W; Knolle J
Br J Pharmacol; 1991 Mar; 102(3):769-73. PubMed ID: 1364851
[TBL] [Abstract][Full Text] [Related]
28. Effect of captopril in the presence of kinin B2 receptor antagonist on duration of survival after prolonged coronary artery ligation in hypertensive rats.
Sharma JN; Abbas SA
Methods Find Exp Clin Pharmacol; 2006 May; 28(4):217-21. PubMed ID: 16801982
[TBL] [Abstract][Full Text] [Related]
29. Effects of converting enzyme inhibition on endothelial bradykinin metabolism and endothelium-dependent vascular relaxation.
Bossaller C; Auch-Schwelk W; Gräfe M; Graf K; Baumgarten C; Fleck E
Agents Actions Suppl; 1992; 38 ( Pt 3)():171-7. PubMed ID: 1334349
[TBL] [Abstract][Full Text] [Related]
30. Polar secretion of endothelin-1 by cultured endothelial cells.
Wagner OF; Christ G; Wojta J; Vierhapper H; Parzer S; Nowotny PJ; Schneider B; Waldhäusl W; Binder BR
J Biol Chem; 1992 Aug; 267(23):16066-8. PubMed ID: 1644793
[TBL] [Abstract][Full Text] [Related]
31. Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy.
Busse R; Fleming I; Hecker M
J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S31-6. PubMed ID: 7508049
[TBL] [Abstract][Full Text] [Related]
32. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
[TBL] [Abstract][Full Text] [Related]
33. The effect of angiotensin-converting enzyme inhibition on inflammatory and angiogenic factors in hypercholesterolemia.
Mahmoudabady M; Kazemi N; Niazmand S; Rezaee SA; Soukhtanloo M; Hosseini M
Pharmacol Rep; 2015 Oct; 67(5):837-41. PubMed ID: 26398373
[TBL] [Abstract][Full Text] [Related]
34. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
Sulpizio AC; Pullen MA; Edwards RM; Brooks DP
J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834
[TBL] [Abstract][Full Text] [Related]
35. Endothelial angiotensin-converting enzyme and neutral endopeptidase in isolated human umbilical vein: an effective bradykinin inactivation pathway.
Nowak W; Errasti AE; Armesto AR; Santín Velazque NL; Rothlin RP
Eur J Pharmacol; 2011 Sep; 667(1-3):271-7. PubMed ID: 21651905
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
37. Secretory dysfunction of vascular endothelium limits the effect of angiotensin converting enzyme inhibitor quinapril on aggregation of erythrocytes in experimental hypertension.
Korbut RA; Madej J; Adamek-Guzik T; Korbut R
J Physiol Pharmacol; 2003 Sep; 54(3):397-408. PubMed ID: 14566078
[TBL] [Abstract][Full Text] [Related]
38. Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors.
Scharfstein J; Schmitz V; Morandi V; Capella MM; Lima AP; Morrot A; Juliano L; Müller-Esterl W
J Exp Med; 2000 Nov; 192(9):1289-300. PubMed ID: 11067878
[TBL] [Abstract][Full Text] [Related]
39. Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat.
Arbin V; Claperon N; Fournié-Zaluski MC; Roques BP; Peyroux J
Br J Pharmacol; 2001 Jun; 133(4):495-502. PubMed ID: 11399666
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin II increases the release of endothelin-1 from human cultured endothelial cells but does not regulate its circulating levels.
Ferri C; Desideri G; Baldoncini R; Bellini C; Valenti M; Santucci A; De Mattia G
Clin Sci (Lond); 1999 Mar; 96(3):261-70. PubMed ID: 10029562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
